Comment
. 2007 Nov;56(11):3876; author reply 2876-7.
doi: 10.1002/art.23064.
Why publish a secondary analysis of only one treatment group in the Behandelstrategieën voor Reumatoide Artritis trial? Comment on the article by van der Bijl et al
- PMID: 17968912
- DOI: 10.1002/art.23064
Item in Clipboard
Comment
Why publish a secondary analysis of only one treatment group in the Behandelstrategieën voor Reumatoide Artritis trial? Comment on the article by van der Bijl et al
Arthritis Rheum.
2007 Nov.
No abstract available
Comment on
-
Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis.Arthritis Rheum. 2007 Jul;56(7):2129-34. doi: 10.1002/art.22718. Arthritis Rheum. 2007. PMID: 17599726 Clinical Trial.
Similar articles
-
Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.Arthritis Rheum. 2008 May;58(5):1293-8. doi: 10.1002/art.23439. Arthritis Rheum. 2008. PMID: 18438829 Clinical Trial.
-
Efficacy of intraarticular infliximab administration in patients with recurrent gonarthritis: comment on the article by van der Bijl et al.Arthritis Care Res (Hoboken). 2010 Feb;62(2):291; author reply 291-2. doi: 10.1002/acr.20081. Arthritis Care Res (Hoboken). 2010. PMID: 20191533 No abstract available.
-
Autoimmune diseases. The B cell slayer.Science. 2007 Nov 23;318(5854):1232-3. doi: 10.1126/science.318.5854.1232. Science. 2007. PMID: 18033858 No abstract available.
-
A novel approach to the development of anti-inflammatory agents: adenosine release at inflamed sites.J Investig Med. 1995 Feb;43(1):50-7. J Investig Med. 1995. PMID: 7719759 Review. No abstract available.
-
[Biopharmaceuticals in the treatment of rheumatoid arthritis].Ugeskr Laeger. 2008 Jun 9;170(24):2108-10. Ugeskr Laeger. 2008. PMID: 18572481 Review. Danish.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
